105 related articles for article (PubMed ID: 15016127)
21. Increased leukocyte-platelet interactions during circulatory support with left ventricular assist devices.
Radovancevic R; Matijevic N; Bracey AW; Radovancevic B; Elayda M; Gregoric ID; Frazier OH
ASAIO J; 2009; 55(5):459-64. PubMed ID: 19730003
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand.
Menchén L; Marín-Jiménez I; Arias-Salgado EG; Fontela T; Hernández-Sampelayo P; Rodríguez MC; Butta NV
Gut; 2009 Jul; 58(7):920-8. PubMed ID: 19039088
[TBL] [Abstract][Full Text] [Related]
23. High glucose levels enhance platelet activation: involvement of multiple mechanisms.
Sudic D; Razmara M; Forslund M; Ji Q; Hjemdahl P; Li N
Br J Haematol; 2006 May; 133(3):315-22. PubMed ID: 16643434
[TBL] [Abstract][Full Text] [Related]
24. Exercise training decreases plasma levels of soluble CD40 ligand and P-selectin in patients with chronic heart failure.
Bjørnstad HH; Bruvik J; Bjørnstad AB; Hjellestad BL; Damås JK; Aukrust P
Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):43-8. PubMed ID: 18277184
[TBL] [Abstract][Full Text] [Related]
25. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
26. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE
Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179
[TBL] [Abstract][Full Text] [Related]
27. Platelet activation status decreases after menopause.
Aldrighi JM; Oliveira RL; D'Amico E; Rocha T; Gebara OE; Rosano GM; Ramires JA
Gynecol Endocrinol; 2005 May; 20(5):249-57. PubMed ID: 16019369
[TBL] [Abstract][Full Text] [Related]
28. Microparticle-associated P-selectin reflects platelet activation in preeclampsia.
Lok CA; Nieuwland R; Sturk A; Hau CM; Boer K; Vanbavel E; Vanderpost JA
Platelets; 2007 Feb; 18(1):68-72. PubMed ID: 17365856
[TBL] [Abstract][Full Text] [Related]
29. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention.
Lim HS; Blann AD; Lip GY
Circulation; 2004 Jun; 109(21):2524-8. PubMed ID: 15136493
[TBL] [Abstract][Full Text] [Related]
30. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
[TBL] [Abstract][Full Text] [Related]
31. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
Nadar S; Blann AD; Lip GY
Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
[TBL] [Abstract][Full Text] [Related]
32. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
[TBL] [Abstract][Full Text] [Related]
33. Effects of immunosuppressive drugs on platelet aggregation and soluble P-selectin levels in renal transplant patients.
Sahin G; Akay OM; Kus E; Bal C; Yalcin AU; Gulbas Z
Ren Fail; 2009; 31(2):111-7. PubMed ID: 19212907
[TBL] [Abstract][Full Text] [Related]
34. Decreased platelet reactivity identified by whole blood flow cytometry in Fanconi anaemia patients.
Holzhauer S; Sitaru AG; Ebell W; Schindler D; Hanenberg H; Wirbelauer J; Walter U; Grossmann R
Thromb Haemost; 2007 Dec; 98(6):1291-7. PubMed ID: 18064327
[TBL] [Abstract][Full Text] [Related]
35. NADPH oxidase-mediated platelet isoprostane over-production in cirrhotic patients: implication for platelet activation.
Basili S; Raparelli V; Riggio O; Merli M; Carnevale R; Angelico F; Tellan G; Pignatelli P; Violi F;
Liver Int; 2011 Nov; 31(10):1533-40. PubMed ID: 22093328
[TBL] [Abstract][Full Text] [Related]
36. Coagulation activation and expression of CD40 ligand on platelets upon in vitro lipopolysaccharide-challenge in patients with unstable angina.
Kälsch T; Nguyen XD; Elmas E; Grebert N; Süselbeck T; Klüter H; Borggrefe M; Dempfle CE
Int J Cardiol; 2006 Aug; 111(2):217-23. PubMed ID: 16182391
[TBL] [Abstract][Full Text] [Related]
37. The effects of maximal treadmill graded exercise testing on haemorheological, haemodynamic and flow cytometry platelet markers in patients with systolic or diastolic heart failure.
Chung I; Goyal D; Macfadyen RJ; Lip GY
Eur J Clin Invest; 2008 Mar; 38(3):150-8. PubMed ID: 18257777
[TBL] [Abstract][Full Text] [Related]
38. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
[TBL] [Abstract][Full Text] [Related]
39. Platelet-leukocyte mixed conjugates in patients with atrial fibrillation.
Alberti S; Angeloni G; Tamburrelli C; Pampuch A; Izzi B; Messano L; Parisi Q; Santamaria M; Donati MB; de Gaetano G; Cerletti C
Platelets; 2009 Jun; 20(4):235-41. PubMed ID: 19459131
[TBL] [Abstract][Full Text] [Related]
40. Comparison of changes in circulating platelet-derived microparticles and platelet surface P-selectin expression after coronary stent implantation.
Inoue T; Hikichi Y; Morooka T; Yoshida K; Fujimatsu D; Komoda H; Kameda M; Nonaka M; Sohma R; Hashimoto S; Node K
Platelets; 2006 Sep; 17(6):416-20. PubMed ID: 16973503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
